Literature DB >> 18536864

Acute hemodynamic effects of intravenous amiodarone treatment in paediatric cardiac surgical patients.

Nikolaus A Haas1, Christoph K Camphausen.   

Abstract

INTRODUCTION: The haemodynamic response after an IV-loading dose of amiodarone followed by continuous infusion for various supraventricular and ventricular tachycardias was studied in children immediately after corrective surgery for congenital heart defects.
METHODS: Observational study over a 10-year period. Seventy-one out of 2651 patients (2,885 procedures, 2,106 bypass procedures) received amiodarone therapy for newly detected postoperative tachyarrhythmias. All patients received catecholamine infusions as standard post-op therapy to support cardiac function and output. In most cases a loading dose of amiodarone was given over 1-4 h followed by a continuous infusion. Catecholamine infusion dose requirements were monitored as was heart rate, blood pressure, central venous pressure, and sedation dose requirements pre treatment and at 0.5, 1, 2, 4, 8, 12 and 24 h after the begin of the amiodarone administration.
RESULTS: After 1 h there was a significant decrease of heart rate from 194.5 bpm (+/-31.9) to 157.5 bpm (+/-34.3) and an increase of the mean arterial blood pressure from 52.8 (+/-11.4) to 56.0 (+/-9.8) mmHg, with a subsequent decrease of filling pressures. The catecholamine dose required could be decreased as could the dose for sedation. Rate control was achieved at 277.4 min (+/-344) and rhythm control at 685.8 min (+/-988.5) respectively. Based on a preliminary interim analysis a specific treatment protocol was established and used in 32 patients.
CONCLUSION: A slow bolus administration of 5 mg/kg amiodarone over at least 60 min followed by one or two additional boluses or a continuous infusion with 10-20 mg/kg day(-1) is a safe treatment strategy without the need for additional inotropic support and with dramatic improvement of heart rate, blood pressure and filling pressures. This protocol can be recommended for paediatric patients in the early postoperative setting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18536864     DOI: 10.1007/s00392-008-0683-4

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  59 in total

1.  Acute pulmonary toxicity in an infant from intravenous amiodarone.

Authors:  C J Daniels; D A Schutte; S Hammond; W H Franklin
Journal:  Am J Cardiol       Date:  1997-10-15       Impact factor: 2.778

2.  Successful use of an intravenous infusion of flecainide and amiodarone for a refractory combination of postoperative junctional and ectopic tachycardias.

Authors:  Nikolaus A Haas; Scott Fox; Jonathan R Skinner
Journal:  Cardiol Young       Date:  2005-08       Impact factor: 1.093

3.  Use of intravenous amiodarone for postoperative junctional ectopic tachycardia in children.

Authors:  W P Laird; C S Snyder; N J Kertesz; R A Friedman; D Miller; A L Fenrich
Journal:  Pediatr Cardiol       Date:  2002-10-10       Impact factor: 1.655

4.  Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias.

Authors:  H F Clemo; M A Wood; D M Gilligan; K A Ellenbogen
Journal:  Am J Cardiol       Date:  1998-03-01       Impact factor: 2.778

5.  Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease.

Authors:  E P Walsh; J P Saul; G F Sholler; J K Triedman; R A Jonas; J E Mayer; D L Wessel
Journal:  J Am Coll Cardiol       Date:  1997-04       Impact factor: 24.094

6.  The suitability of the Pediatric Index of Mortality (PIM), PIM2, the Pediatric Risk of Mortality (PRISM), and PRISM III for monitoring the quality of pediatric intensive care in Australia and New Zealand.

Authors:  Anthony Slater; Frank Shann
Journal:  Pediatr Crit Care Med       Date:  2004-09       Impact factor: 3.624

7.  Comparative hemodynamic effects of amiodarone, sotalol, and d-sotalol.

Authors:  N Twidale; P Roberts-Thomson; R J McRitchie
Journal:  Am Heart J       Date:  1993-07       Impact factor: 4.749

8.  Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy.

Authors:  A L Fenrich; J C Perry; R A Friedman
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

9.  Amiodarone management of junctional ectopic tachycardia after cardiac surgery in children.

Authors:  P Raja; R E Hawker; A Chaikitpinyo; S G Cooper; K C Lau; G R Nunn; T B Cartmill; G F Sholler
Journal:  Br Heart J       Date:  1994-09

10.  Amiodarone-induced 2 to 1 atrioventricular block in association with prolongation of the QT interval.

Authors:  Colin J McMahon; William P Laird; Arnold L Fenrich
Journal:  Cardiol Young       Date:  2003-06       Impact factor: 1.093

View more
  3 in total

1.  Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

2.  Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

Review 3.  Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?

Authors:  Martin Schwaiblmair; Thomas Berghaus; Thomas Haeckel; Theodor Wagner; Wolfgang von Scheidt
Journal:  Clin Res Cardiol       Date:  2010-07-10       Impact factor: 5.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.